• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ZIOPHARM Oncology Inc

+ Add to Watchlist

WEK:GR

3.641 EUR 0.264 7.82%

As of 13:35:22 ET on 12/19/2014.

Snapshot for ZIOPHARM Oncology Inc (WEK)

Open: 3.442 Day's Range: 3.440 - 3.804 Volume: 0
Previous Close: 3.377 52wk Range: 1.863 - 3.949 1-Yr Rtn: +25.86%

Stock Chart for WEK

No chart data available.
  • WEK:GR 3.506
  • 1D
  • 1M
  • 1Y
3.377
Interactive WEK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for WEK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4400
Est. PEG Ratio -
Market Cap (M EUR) 373.97
Shares Outstanding (M) 102.71
30 Day Average Volume 225
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for WEK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for WEK

ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs.

Jonathan J LewisChief Executive OfficerCaesar J BelbelExec VP/Chief Legal Ofcr/Secy
Kevin G LafondVP:Finance/Chief Accounting Ofcr
More Company Profile & Key Executives for WEK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil